What is the impact of antiviral treatment for people who inject drugs on the overall number of new hepatitis C infections within the population of injecting drug users?
Not Applicable
- Conditions
- Hepatitis CInfections and InfestationsChronic viral hepatitis C
- Registration Number
- ISRCTN72038467
- Lead Sponsor
- niversity of Dundee
- Brief Summary
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31551376/ (added 15/09/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 555
Inclusion Criteria
1. HCV diagnosis
2. Injecting drug use
3. Aged 18 years or over
Exclusion Criteria
1. Mental health or behavioural problems e.g. psychosis, aggressiveness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The utility status of HCV infection and the change in utility with treatment and cure will be measured using the EQ5D5L questionnaire at treatment start, treatment end, 12 weeks following end of treatment and one year following treatment.
- Secondary Outcome Measures
Name Time Method 1. The experiences and perceptions of service providers will be measured using qualitative interviews and/or focus groups during the latter stages of treatment scale -up during 2018-2019. <br>2. The experiences and perceptions of individuals undergoing HCV treatment will be measured using qualitative interviews post treatment and around one year later. <br>3. The experiences and perceptions of individuals refusing HCV treatment will be measured using qualitative interviews once following refusal of treatment.